These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9179283)
61. Regional differences exist in allogeneic stem cell transplantation rates for acute leukemia. Miura Y; Yamaguchi T; Azuma T; Hamaki T; Kodama Y; Kusumi E; Matsumura T; Nakamura T; Kami M; Komatsu T Int J Hematol; 2008 Mar; 87(2):236-238. PubMed ID: 18288563 [No Abstract] [Full Text] [Related]
62. [Hematologic Malignancies/Pediatric Malignancies Revolution Acute Lymphoblastic Leukemia Treatment]. Yano S Gan To Kagaku Ryoho; 2024 May; 51(5):509-510. PubMed ID: 38881058 [No Abstract] [Full Text] [Related]
63. Immune Therapy of Lympho-Hemopoietic Malignancies. Echchannaoui H; Theobald M Oncol Res Treat; 2017; 40(11):652-653. PubMed ID: 29065397 [No Abstract] [Full Text] [Related]
64. Role of stem cell transplant in pediatric cancers. Oncology (Williston Park); 2007 Aug; 21(9):1032; author reply 1032. PubMed ID: 17910310 [No Abstract] [Full Text] [Related]
65. Correcting 2 more myths regarding transplants for AML in second remission. Gale RP; Lazarus HM Blood; 2014 Jan; 123(5):794. PubMed ID: 24482501 [No Abstract] [Full Text] [Related]
67. Relapse post hematopoietic SCT remains the Achilles heel for the field. Frangoul H; Jagasia M Bone Marrow Transplant; 2014 Aug; 49(8):997-8. PubMed ID: 25096916 [No Abstract] [Full Text] [Related]
68. Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation. Giammarco S; Bellesi S; Metafuni E; Rossi M; Minnella G; Bacigalupo A; Sica S; Chiusolo P Ann Hematol; 2022 Nov; 101(11):2565-2566. PubMed ID: 35994061 [No Abstract] [Full Text] [Related]
69. Autologous bone marrow transplantation in lymphoid malignancies. Jackson GH Transpl Immunol; 1994 Jun; 2(2):155-6. PubMed ID: 7953317 [No Abstract] [Full Text] [Related]
70. Secondary osteosarcoma arising after treatment for childhood hematologic malignancies. Okada A; Hatori M; Hosaka M; Watanuki M; Itoi E Ups J Med Sci; 2009; 114(4):249-55. PubMed ID: 19961270 [TBL] [Abstract][Full Text] [Related]
71. Late effects in survivors of infantile acute leukemia: a study of the L.E.A program. Gandemer V; Bonneau J; Oudin C; Berbis J; Bertrand Y; Tabone MD; Ducassou S; Chastagner P; Brethon B; Dalle JH; Thouvenin S; Poiree M; Plantaz D; Kanold J; Sirvent N; Lutz P; Hamidou Z; Baruchel A; Leverger G; Auquier P; Michel G Blood Cancer J; 2017 Jan; 7(1):e518. PubMed ID: 28106878 [No Abstract] [Full Text] [Related]
72. Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Hudson MM; Neglia JP; Woods WG; Sandlund JT; Pui CH; Kun LE; Robison LL; Green DM Pediatr Blood Cancer; 2012 Mar; 58(3):334-43. PubMed ID: 22038641 [TBL] [Abstract][Full Text] [Related]
73. Geriatric Hematology Research presented at the 2018 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology Perspective Paper. Loh KP; Christofyllakis K; Huang LW; Mims A J Geriatr Oncol; 2019 Mar; 10(2):186-191. PubMed ID: 30661875 [No Abstract] [Full Text] [Related]
74. Induction Dosage of Propofol for Repeated Sedations in Children With Hematological Disorders. Moretto A; Zanella A; Ciceri V; Rota M; Scaravilli V; Beltrama V; Bosatra M; Pesenti A J Pediatr Hematol Oncol; 2018 Jul; 40(5):e295-e298. PubMed ID: 29668546 [TBL] [Abstract][Full Text] [Related]
75. [Advances in the target therapy of hematological malignancies]. Niu T; Liu T Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):642-6. PubMed ID: 25286692 [TBL] [Abstract][Full Text] [Related]
76. Exploring Big Data in Hematological Malignancies: Challenges and Opportunities. Westin GF; Dias AL; Go RS Curr Hematol Malig Rep; 2016 Aug; 11(4):271-9. PubMed ID: 27177742 [TBL] [Abstract][Full Text] [Related]
77. Problems in diagnosing and treating childhood hematopoietic malignancies in Cameroon, West Africa. Fosi-Mbantenkhu J Am J Pediatr Hematol Oncol; 1990; 12(3):378-80. PubMed ID: 2240486 [No Abstract] [Full Text] [Related]
78. [Treatment of acute Leukemia]. Usui N Gan To Kagaku Ryoho; 2014 May; 41(5):560-6. PubMed ID: 24956627 [No Abstract] [Full Text] [Related]
79. Blood use in hematologic malignancies: a nationwide overview in Sweden between 2000 and 2010. Zhao J; Rydén J; Wikman A; Norda R; Stanworth SJ; Hjalgrim H; Edgren G Transfusion; 2018 Feb; 58(2):390-401. PubMed ID: 29250794 [TBL] [Abstract][Full Text] [Related]
80. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Brissot E; Labopin M; Baron F; Bazarbachi A; Bug G; Ciceri F; Esteve J; Giebel S; Gilleece MH; Gorin NC; Lanza F; Peric Z; Ruggeri A; Sanz J; Savani BN; Schmid C; Shouval R; Spyridonidis A; Versluis J; Nagler A; Mohty M Bone Marrow Transplant; 2021 Mar; 56(3):532-535. PubMed ID: 32528122 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]